R&D Systems™ Recombinant Human RECK Fc Chimera Protein

Catalog No.	Quantity
10-309-RE050	50 μg

Catalog No. 10-309-RE050 Supplier R&D Systems™ Supplier No. 10309RE050

Description

Measured by its binding ability in a functional ELISA.

When Recombinant Human RECK Fc Chimera is immobilized at 2 μg/mL (100 μL/well), Recombinant Human TEM5/GPR124 His-tag binds with an ED50 of 0.7 to 5.6 μg/mL

Specifications

• Accession Number: O95980
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 8434
• Molecular Weight (g/mol): 127 kDa
• Name: hRECK, membrane-anchored glycoprotein (metastasis and invasion), reversion-inducing-cysteine-rich protein with kazal motifs, ST15, ST15reversion-inducing cysteine-rich protein with Kazal motifs, suppression of tumorigenicity 15 (reversion-inducing-cysteine-rich protein withkazal motifs), suppression of tumorigenicity 5 (reversion-inducing-cysteine-rich protein withkazal motifs), Suppressor of tumorigenicity 15 protein
• Quantity: 50 μg
• Source:

  Human embryonic kidney cell, HEK293-derived human RECK protein

  Human RECK (Met1-Pro941) Accession # O95980IEGRMDHuman IgG1 (Pro100-Lys330)N-terminus C-terminus

• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500 μg/mL in water.
• Buffer: Lyophilized from a 0.2 μm filtered solution in Tris and NaCl.
• Endotoxin Level: <0.10 EU per 1 μg of the protein by the LAL method.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.